Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imre Noth

Showing results (161-170 of 211) with videos related to

Pageof 22
Sort By:
American Journal of Respiratory and Critical Care Medicine|March 14, 2024
The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment DecisionsJuergen Behr, Margaret L Salisbury, Simon L F Walsh, et al.
American Journal of Respiratory and Critical Care Medicine|May 19, 2026
Gut microbiota associate with disease severity and survival in idiopathic pulmonary fibrosisJohn S Kim, Abigail Loe, Shwu-Fan Ma, et al.
American Journal of Respiratory and Critical Care Medicine|April 13, 2022
Rare and Common Variants in <i>KIF15</i> Contribute to Genetic Risk of Idiopathic Pulmonary FibrosisDavid Zhang, Gundula Povysil, Philippe H Kobeissy, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2024
Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation AnalysisJanelle Vu Pugashetti, John S Kim, Swaraj Bose, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association studyImre Noth, Yingze Zhang, Shwu-Fan Ma, et al.
JCI Insight|May 4, 2021
Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPFMiriam S Hohmann, David M Habiel, Milena S Espindola, et al.
The Lancet. Digital Health|November 4, 2022
Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohortHernan P Fainberg, Justin M Oldham, Philip L Molyneau, et al.
American Journal of Respiratory and Critical Care Medicine|April 4, 2024
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision MedicineAyodeji Adegunsoye, Jonathan A Kropski, Juergen Behr, et al.
Medrxiv : the Preprint Server for Health Sciences|May 22, 2023
Antigenic responses are hallmarks of fibrotic interstitial lung diseases independent of underlying etiologiesYoung Me Yoon, Tania E Velez, Vaibhav Upadhyay, et al.
Pageof 22

Showing results (161-170 of 211) with videos related to

Sort By:
Pageof 22
American Journal of Respiratory and Critical Care Medicine|March 14, 2024
The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment DecisionsJuergen Behr, Margaret L Salisbury, Simon L F Walsh, et al.
American Journal of Respiratory and Critical Care Medicine|May 19, 2026
Gut microbiota associate with disease severity and survival in idiopathic pulmonary fibrosisJohn S Kim, Abigail Loe, Shwu-Fan Ma, et al.
American Journal of Respiratory and Critical Care Medicine|April 13, 2022
Rare and Common Variants in <i>KIF15</i> Contribute to Genetic Risk of Idiopathic Pulmonary FibrosisDavid Zhang, Gundula Povysil, Philippe H Kobeissy, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2024
Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation AnalysisJanelle Vu Pugashetti, John S Kim, Swaraj Bose, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association studyImre Noth, Yingze Zhang, Shwu-Fan Ma, et al.
JCI Insight|May 4, 2021
Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPFMiriam S Hohmann, David M Habiel, Milena S Espindola, et al.
The Lancet. Digital Health|November 4, 2022
Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohortHernan P Fainberg, Justin M Oldham, Philip L Molyneau, et al.
American Journal of Respiratory and Critical Care Medicine|April 4, 2024
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision MedicineAyodeji Adegunsoye, Jonathan A Kropski, Juergen Behr, et al.
Medrxiv : the Preprint Server for Health Sciences|May 22, 2023
Antigenic responses are hallmarks of fibrotic interstitial lung diseases independent of underlying etiologiesYoung Me Yoon, Tania E Velez, Vaibhav Upadhyay, et al.
Pageof 22